Curative Inc. was founded to develop tests for sepsis in January 2020 and pivoted to COVID-19 in early March 2020 upon realizing the urgent need for test development and production in the United States. Curative is backed by Deep Tech venture capital firm DCVC and is currently operational within a CLIA-approved lab in Los Angeles, CA. Founded by Fred Turner and comprised of a team of doctors, researchers, robotics engineers, and health industry experts, Curative is rapidly scaling its simple-to-use oral fluid COVID-19 tests to reach the groups most in need of testing.
Curative Inc. was founded to develop tests for sepsis in January 2020 and pivoted to COVID-19 in early March 2020 upon realizing the urgent need for test development and production in the United States. Curative is backed by Deep Tech venture capital firm DCVC and is currently operational within a CLIA-approved lab in Los Angeles, CA. Founded by Fred Turner and comprised of a team of doctors, researchers, robotics engineers, and health industry experts, Curative is rapidly scaling its simple-to-use oral fluid COVID-19 tests to reach the groups most in need of testing.